Expanded CD34 + human umbilical cord blood cells generate multiple lymphohematopoietic lineages in NOD-scid IL2iγ null mice

Experimental Biology and Medicine

Volumn 233, Issue 8, 2008, Pages 997-1012

  Giassi, Lisa J ^a   Pearson, Todd ^a   Shultz, Leonard D ^b   Laning, Joseph ^c   Biber, Kristin ^c   Kraus, Morey ^c   Woda, Bruce A ^a   Schmidt, Madelyn R ^a   Woodland, Robert T ^a   Rossini, Aldo A ^a   Greiner, Dale L ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b JACKSON LABORATORY   (United States)

^c Viacord Inc   (United States)

Author keywords

Ex vivo expansion; Human; Immune response; NOD scid IL2r null mice; SCID; TNF ; Umbilical cord blood

Indexed keywords

B CELL ACTIVATING FACTOR; CYTOKINE; INTERLEUKIN 2 RECEPTOR GAMMA; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; CD34 ANTIGEN; IL2RG PROTEIN, MOUSE; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CD34 SELECTION; CELL ACTIVITY; CELL CULTURE; CELL DIFFERENTIATION; CELL EXPANSION; CELL FUNCTION; CELL LINEAGE; CELL MATURATION; CELLULAR IMMUNITY; CHILD; CONTROLLED STUDY; CROSS LINKING; ERYTHROID CELL; EX VIVO STUDY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC SYSTEM; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNIZATION; LYMPHOID CELL; MALE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; SCID MOUSE; T LYMPHOCYTE; UMBILICAL CORD BLOOD; ANIMAL; BLOOD; CORD BLOOD STEM CELL TRANSPLANTATION; CULTURE TECHNIQUE; CYTOLOGY; GENETICS; HEMATOPOIESIS; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE ACTIVATION; LYMPHOPOIESIS; METHODOLOGY; MOUSE MUTANT; NEWBORN; XENOGRAFT;

MUS;

ANIMALS; ANTIGENS, CD34; B-LYMPHOCYTES; CELL CULTURE TECHNIQUES; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; HEMATOPOIESIS; HUMANS; INFANT, NEWBORN; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; LYMPHOCYTE ACTIVATION; LYMPHOPOIESIS; MALE; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; RECOMBINANT PROTEINS; T-LYMPHOCYTES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HETEROLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 50649116616     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0802-RM-70     Document Type: Article

References (66)

1. Armitage JO. Bone marrow transplantation. N Engl J Med 330:827-838, 1994.
2. + progenitor cells from HLA-mismatched parental donors in children. Bone Marrow Transplant 27:777-783, 2001.
3. Woodard P, Cunningham JM, Benaim E, Chen X, Hale G, Horwitz E, Houston J, Kasow K, Leung W, Wang W, Yusuf U, Handgretinger R. Effective donor lymphohematopoietic reconstitution after haploiden- tical CD34+-selected hematopoietic stem cell transplantation in children with refractory severe aplastic anemia. Bone Marrow Transplant 33:411-118, 2004.
4. Lu L, Shen R-N, Broxmeyer HE. Stem cells from bone marrow, umbilical cord blood and peripheral blood for clinical application: current status and future aplplication. Crit Rev Oncol-Hematol 22:61-78, 1996.
5. Broxmeyer HE, Douglas GW, Hangoc G, Cooper S, Bard J, English D, Arny M, Thomas L, Boyse EA. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 86:3828-3832, 1989.
6. Benito AI, Diaz MA, Gonzalez-Vicent M, Sevilla J, Madero L. Hematopoietic stem cell transplantation using umbilical cord blood progenitors: review of current clinical results. Bone Marrow Transplant 33:675-690, 2004.
7. Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE, Gerson SL, Lazarus HM, Cairo M, Stevens CE, Rubinstein P, Kurtzberg J. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 344: 1815-1822, 2001.
8. Bradley MB, Cairo MS. Cord blood immunology and stem cell transplantation. Hum Immunol 66:431-446, 2005.
9. Holyoake TL, Nicolini FE, Eaves CJ. Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow. Exp Hematol 27:1418-1427, 1999.
10. Brunstein CG, Wagner JE. Umbilical cord blood transplantation and banking. Annu Rev Med 57:403-417, 2006.
11. Rubinstein P. Why cord blood? Hum Immunol 67:398-404, 2006.
12. Schoemans H, Theunissen K, Maertens J, Boogaerts M, Verfaillie C, Wagner J. Adult umbilical cord blood transplantation: a comprehensive review. Bone Marrow Transplant 38:83-93, 2006.
13. Majhail NS, Brunstein CG, Wagner JE. Double umbilical cord blood transplantation. Curr Opin Immunol 18:571-575, 2006.
14. Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, Arcese W, Pasquini R, Ortega J, Souillet G, Ferreira E, Laporte JP, Fernandez M, Chastang C. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 337:373-381, 1997.
15. Rubinstein P, Carriet C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR, Berkowitz RL, Cabbad M, Dobrila NL, Taylor PE, Rosenfield RE, Stevens CE. Outcomes among 562 recipients of placental blood transplants from unrelated donors. N Engl J Med 339: 1565-1569, 1998.
16. Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C, Goldman A, Kersey J, Krivit W, MacMillan ML, Orchard PJ, Peters C, Weisdorf DJ, Ramsay NK, Davies SM. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100:1611-1618, 2002.
17. Weinreb S, Delgado JC, Clavijo OP, Yunis EJ, Bayer-Zwirello L, Polansky L, Deluhery L, Cohn G, Yao JT, Stec TC, Higby D, Anderzejewski C. Transplantation of unrelated cord blood cells. Bone Marrow Transplant 22:193-196, 1998.
18. Barker JN, Wagner JE. Umbilical cord blood transplantation: current practice and future innovations. Crit Rev Oncol Hematol 48:35-43, 2003.
19. de Lima M, St John LS, Wieder ED, Lee MS, McMannis J, Karandish S, Giralt S, Beran M, Couriel D, Korbling M, Bibawi S, Champlin R, Komanduri KV. Double-chimaerism after transplantation of two human leucocyte antigen mismatched, unrelated cord blood units. Br J Haematol 119:773-776, 2002.
20. Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, Miller JS, Wagner JE. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 102:1915-1919, 2003.
21. Hofmeister CC, Zhang J, Knight KL, Le P, Stiff PJ. Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche. Bone Marrow Transplant 39:11-23, 2007.
22. Mohamed AA, Ibrahim AM, El Masry MW, Mansour IM, Khroshied MA, Gouda HM, Riad RM. Ex vivo expansion of stem cells: defining optimum conditions using various cytokines. Lab Hematol 12:86-93, 2006.
23. + cells to generate functional T lymphocytes and dendritic cells. Stem Cells 24:2150-2157, 2006.
24. -. Stem Cells 25:107-114, 2007.
25. Ito Y, Hasauda H, Kitajima T, Kiyono T. Ex vivo expansion of human cord blood hematopoietic progenitor cells using glutaraldehyde-fixed human bone marrow stromal cells. J Biosci Bioeng 102:467-469, 2006.
26. -) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin. J Exp Med 183:2551-2558, 1996.
27. McNiece I, Kubegov D, Kerzic P, Shpall EJ, Gross S. Increased expansion and differentiation of cord blood products using a two-step expansion culture. Exp Hematol 28:1181-1186, 2000.
28. McNiece I, Jones R, Bearman SI, Cagnoni P, Nieto Y, Franklin W, Ryder J, Steele A, Stoltz J, Russell P, McDermitt J, Hogan C, Murphy J, Shpall EJ. Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer. Blood 96:3001-3007, 2000.
29. Conneally E, Cashman J, Petzer A, Eaves C. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho- myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc Natl Acad Sci USA 94:9836-9841, 1997.
30. Ueda T, Tsuji K, Yoshino H, Ebihara Y, Yagasaki H, Hisakawa H, Mitsui T, Manabe A, Tanaka R, Kobayashi K, Ito M, Yasukawa K, Nakahata T. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. J Clin Invest 105:1013-1021, 2000.
31. Bhatia M, Wang JCY, Kapp U, Bonnet D, Dick JE. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci USA 94:5320-5325, 1997.
32. Chute JP, Muramoto G, Fung J, Oxford C. Quantitative analysis demonstrates expansion of SCID-repopulating cells and increased engraftment capacity in human cord blood following ex vivo culture with human brain endothelial cells. Stem Cells 22:202-215, 2004.
33. + cord blood cells. Blood 93:1097-1105, 1999.
34. Shultz LD, Ishikawa F, Greiner DL. Humanized mice in translational biomedical research. Nat Rev Immunol 7:118-130, 2007.
35. Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B, McKenna S, Mobraaten L, Rajan TV, Greiner DL, Leiter EH. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 154:180-191, 1995.
36. null mice engrafted with mobilized human hematopoietic stem cell. J Immunol 174:6477-6489, 2005.
37. null mice: a new model system with increased levels of human peripheral leukocyte and hematmopoietic stem cell engraftment. Transplantation 76:1036-1042, 2003.
38. Wernette CM, Frasch CE, Madore D, Carlone G, Goldblatt D, Plikaytis B, Benjamin W, Quataert SA, Hildreth S, Sikkema DJ, Kayhty H, Jonsdottir I, Nahm MH. Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin Diagn Lab Immunol 10:514-519, 2003.
39. null) NOD/SCID mice are excellent recipients for studying human stem cell function. Blood 95:3102-3105, 2000.
40. Greiner DL, Shultz LD, Yates J, Appel MC, Perdrizet G, Hesselton RM, Schweitzer I, Beamer WG, Shultz KL, Pelsue SC, Leif JH, Rajan TV. Improved engraftment of human spleen cells in NOD/LtSz-scid scid mice as compared with C.B-17-scid scid mice. Am J Path 146:888-902, 1995.
41. + T cell engraftment in β2-microglobulin-deficient NOD-scid mice. J Immunol 158:3578-3586, 1997.
42. Christianson SW, Greiner DL, Schweitzer IB, Gott B, Beamer GL, Schweitzer PA, Hesselton RM, Shultz LD. Role of natural killer cells on engraftment of human lymphoid cells and on metastasis of human T-lymphoblastoid leukemia cells in C57BL/6J-scid mice and in C57BL/6J-scid bg mice. Cell Immunol 171:186-199, 1996.
43. Lowry PA, Shultz LD, Greiner DL, Hesselton RA, Kittler ELW, Tiarks CY, Rao SS, Reilly J, Leif JH, Ramshaw H, Steward FM, Quesenberry PJ. Improved engraftment of human cord blood stem cells in NOD/LtSz-scid scid mice following irradiation or multiple day injections into unirradiated recipients. Biol Blood Marrow Transplant 2:15-23, 1996.
44. Glimm H, Eisterer W, Lee K, Cashman J, Holyoake TL, Nicolini F, Shultz LD, von Kalle C, Eaves CJ. Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-beta2 microglobulin-null mice. J Clin Invest 107:199-206, 2001.
45. + cells. Exp Hematol 31:551-558, 2003.
46. Samira S, Ferrand C, Peled A, Nagler A, Tovbin Y, Ben Hur H, Taylor N, Globerson A, Lapidot T. Tumor necrosis factor promotes human T-cell development in nonobese diabetic/severe combined immunodeficient mice. Stem Cells 22:1085-1100, 2004.
47. Ringden O, Le Blanc K. Allogeneic hematopoietic stem cell transplantation: state of the art and new perspectives. APMIS 113:813-830, 2005.
48. Aschan J. Allogeneic haematopoietic stem cell transplantation: current status and future outlook. Br Med Bull 77-78:23-36, 2006.
49. Brunstein CG, Baker KS, Wagner JE. Umbilical cord blood transplantation for myeloid malignancies. Curr Opin Hematol 14:162-169, 2007.
50. Haspel RL, Ballen KK. Double cord blood transplants: filling a niche? Stem Cell Rev 2:81-86, 2006.
51. Gan OI, Murdoch B, Larochelle A, Dick JE. Differential maintenance of primitive human SCID-repopulating cells, clonogenic progenitors, and long-term culture-initiating cells after incubation on human bone marrow stromal cells. Blood 90:641-650, 1997.
52. Yamaguchi M, Hirayama F, Kanai M, Sato N, Fukazawa K, Yamashita K, Sawada K, Koike T, Kuwabara M, Ikeda H, Ikebuchi K. Serum-free coculture system for ex vivo expansion of human cord blood primitive progenitors and SCID mouse-reconstituting cells using human bone marrow primary stromal cells. Exp Hematol 29:174-182, 2001.
53. Zhang Y, Li C, Jiang X, Zhang S, Wu Y, Liu B, Tang P, Mao N. Human placenta-derived mesenchymal progenitor cells support culture expansion of long-term culture-initiating cells from cord blood CD34+cells. Exp Hematol 32:657-664, 2004.
54. + hematopoietic stem cells and for chondrogenic differentiation. Haematologica 89:837-844, 2004.
55. + cells with retro-transduced hMSCs leads to effective amplification of long-term culture-initiating cells. World J Gastroenterol 12:393-402, 2006.
56. Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, Yoshimoto G, Watanabe T, Akashi K, Shultz LD, Harada M. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor gamma chain null mice. Blood 106:1565-1573, 2005.
57. Pearson T, Shultz LD, Greiner DL. Humanized SCID mice for biomedical research.
58. + cord blood cells. Exp Hematol 35:1272-1278, 2007.
59. Ware CF. Network communications: lymphotoxins, LIGHT, and TNF. Annu Rev Immunol 23:787-819, 2005.
60. Shriner AK, Smithson SL, Prinz DM, Rabquer B, Khuder S, Goomber R, Westerink MA. Comparison of the human immune response to conjugate and polysaccharide pneumococcal vaccination using a reconstituted SCID mouse model. Vaccine 24:7197-7203, 2006.
61. Scandling JD, Busque S, Dejbakhsh-Jones S, Benike C, Millan MT, Shizuru JA, Hoppe RT, Lowsky R, Engleman EG, Strober S. Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med 358:362-368, 2008.
62. Kawai T, Cosimi AB, Spitzer TR, Tolkoff-Rubin N, Suthanthiran M, Saidman SL, Shaffer J, Preffer FI, Ding R, Sharma V, Fishman JA, Dey B, Ko DS, Hertl M, Goes NB, Wong W, Williams WW Jr, Colvin RB, Sykes M, Sachs DH. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 358:353-361, 2008.
63. Sorli CH, Greiner DL, Mordes JP, Rossini AA. Stem cell transplantation for treatment of autoimmune diseases. Graft 1:71-81, 1998.
64. Passweg J, Tyndall A. Autologous stem cell transplantation in autoimmune diseases. Semin Hematol 44:278-285, 2007.
65. Alderuccio F, Siatskas C, Chan J, Field J, Murphy K, Nasa Z, Toh BH. Haematopoietic stem cell gene therapy to treat autoimmune disease. Curr Stem Cell Res Ther 1:279-287, 2006.
66. Marmont AM. Will hematopoietic stem cell transplantation cure human autoimmune diseases? J Autoimmun 30:145-150, 2008.